Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn MoreIQVIA’s Medical Data Index (MDI) provides life sciences companies with an overall market view on primary care diagnoses and treatments patterns. It is a quarterly summary of general practice (GP) prescribing data linked to a diagnosis, which delivers insights on what products are prescribed to treat diseases and enables monitoring of primary care prescribing trends.
Download the Factsheet or contact us for more information
IQVIA's Medical Data Index (MDI) covers the England primary care market offering full access to aggregated data for all drug and diagnosis classes for patient and disease profiling, monitoring trends in prescribing, indication splits and opportunity assessment and is ideally placed for looking at trends and benchmarking.
Reports are available via IQVIA Analysis Manager (IAM) or MIDAS. IQVIA Analysis Manager cube availability:
Subscribe free of charge to IQVIA's Market Intelligence Newsletter to receive exclusive content on the latest key market insights and trends from the UK healthcare industry.
Derived from primary care electronic medical records, LPD can be used to investigate patient profiles, alongside treatment and pathway questions.
MIDAS is country level audits of medical data (MDI) used for measuring global pharma performance
